Fig. 1.
Invasive disease-free survival (iDFS) of HER2-positive/BRCA mutated (HER2+BRCA+) cases vs. HER2-positive/BRCA wild type (HER2+BRCA-), HER2-negative/BRCA mutated (HER2-BRCA+), and HER2-negative/BRCA wild type (HER2-BRCA-) controls.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.